SPIRIVA RESPIMAT has a Demonstrated Safety Profile1
Multiple clinical trials, with almost 4,500 asthma patients, confirmed the demonstrated safety profile of SPIRIVA RESPIMAT.1
|SPIRIVA RESPIMAT, 2.5 mcg
(two 1.25-mcg puffs) (n=787)
|Pharyngitis||125 (15.9)||91 (12.4)|
|Headache||30 (3.8)||20 (2.7)|
|Bronchitis||26 (3.3)||10 (1.4)|
|Sinusitis||21 (2.7)||10 (1.4)|
*Adverse reactions include a grouping of similar terms.
The adverse reaction profile for pediatric patients (aged 6 to 11 years) and adolescent patients (aged 12 to 17 years) was comparable to that observed in adult patients.1
Add SPIRIVA RESPIMAT for a broad age range of patients1
SPIRIVA RESPIMAT has a demonstrated safety profile for patients as young as 6 years of age1
Drug interactions with concomitant respiratory medications
SPIRIVA RESPIMAT has been used concomitantly with short-acting and long-acting sympathomimetic (beta-agonists) bronchodilators, methylxanthines, oral and inhaled steroids, antihistamines, mucolytics, leukotriene modifiers, cromones, and anti-IgE treatment without increases in adverse reactions.
Drug interactions with other anticholinergics
There is potential for an additive interaction with concomitantly used anticholinergic medications. Therefore, avoid coadministration of SPIRIVA RESPIMAT with other anticholinergic-containing drugs as this may lead to an increase in anticholinergic adverse effects.1
Eligible patients with asthma
may pay as little as $0*
*Eligible patients or patient guardians who are 18 years of age or older may pay as little as $0/month with a maximum savings up to $100/monthly prescription. Card valid for 12 consecutive months from activation date. Eligible patients may re-enroll for additional 12 consecutive-month periods by reactivating expired card, benefits not to exceed program expiration on 12/31/2019. If you live in Massachusetts, card expires on the earlier of July 1, 2019, or date AB-rated generic equivalent is available. One card per patient, not transferrable, and cannot be combined with any other offer. Program not health insurance. Only valid for commercially insured patients in the 50 United States, territories, DC, and Puerto Rico. Not eligible if prescriptions are paid for in part/full by state or federally funded program(s), like Medicare Part D, Medicaid, Vet. Aff., Dept. of Def., or Tricare and where prohibited by law. Offer may change at any time, without notice.